Pacific Biosciences of California Inc (NASDAQ:PACB)
| 4.57 Delayed Data As of Jun 29 |  -0.29 / -5.97%Today’s Change | 3.85 Today|||52-Week Range 36.36 | -77.66% Year-to-Date |
Latest PACB News | Press Releases
No recent news for Pacific Biosciences of California Inc.
Today’s Trading
| Previous close | 4.86 |
| Today’s open | 4.80 |
| Day’s range | 4.56 - 4.84 |
| Volume | 6,200,344 |
| Average volume (3 months) | 6,638,648 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | -598.76% |
| Earnings growth (this year) | -53.56% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +65.43% |
| P/E ratio | NM |
| Price/Sales | 32.00 |
| Price/Book | 1.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HBIOHarvard Bioscience I... | -0.05 | -1.37% |
| --Standard BioTools In... | -0.14 | -8.00% |
| LABStandard BioTools In... | -0.14 | -8.00% |
| BFNHBioForce Nanoscience... | +0.18 | +6.57% |
Data as of 4:00pm ET, 06/29/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $130.5M |
| Annual profit (last year) | -$181.2M |
| Net profit margin | -138.85% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Menlo Park, California |
Forecasts
